Similar articles

• Functional antagonistic properties of clozapine at the 5-HT3 receptor.

  Hermann B, Wetzel CH, Pestel E, Zieglgänsberger W, Holsboer F, Rupprecht R. Hermann B, et al. Biochem Biophys Res Commun. 1996 Aug 23;225(3):957-60. doi: 10.1006/bbrc.1996.1278. Biochem Biophys Res Commun. 1996. PMID: 8780717
• The effects of clozapine and fluperlapine on the in vivo release and metabolism of dopamine in the striatum and in the prefrontal cortex of freely moving rats.

  Imperato A, Angelucci L. Imperato A, et al. Psychopharmacol Bull. 1989;25(3):383-9. Psychopharmacol Bull. 1989. PMID: 2576318
• The effect of typical and atypical antipsychotic drugs on the stimulation of phosphoinositide hydrolysis produced by the 5-HT3 receptor agonist 2-methyl-serotonin.

  Edwards E, Ashby CR Jr, Wang RY. Edwards E, et al. Brain Res. 1991 Apr 5;545(1-2):276-8. doi: 10.1016/0006-8993(91)91296-d. Brain Res. 1991. PMID: 1677603
• Effects of antipsychotic drugs on serotonin receptors.

  Meltzer HY, Nash JF. Meltzer HY, et al. Pharmacol Rev. 1991 Dec;43(4):587-604. Pharmacol Rev. 1991. PMID: 1685568 Review. No abstract available.
• 5-HT6 receptor ligands and their antipsychotic potential.

  Arnt J, Olsen CK. Arnt J, et al. Int Rev Neurobiol. 2011;96:141-61. doi: 10.1016/B978-0-12-385902-0.00006-1. Int Rev Neurobiol. 2011. PMID: 21329787 Review. No abstract available.